[Parkinson's disease].
Terada
Seishi
S
Department of Neuropsychiatry, Graduate School of Medicine and Dentistry, Okayama University.
Kuroda
Shigetoshi
S
Ishizu
Hideki
H
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000209:etiology; D003072:Cognition Disorders / Q000209:etiology; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000453:epidemiology; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D007980:Levodopa; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors